yourstate.us
Home / United States / 21 CFR
21 CFR 556.530

§ 556.530 Pradofloxacin.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 556.530, § 556.530 Pradofloxacin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87804
Permanent ID
ys:prov:87804@1
SHA-256
2075e2662eac0851c3a798e83dbe8ef643d4fb769ec236a4053c71cf6388bc61

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Acceptable daily intake (ADI). The ADI for total residue of pradofloxacin is 2 µg/kg of body weight per day. (b) Tolerances. The tolerances for pradofloxacin (marker residue) are: (1) Cattle. Kidney (target tissue): 30 ppb. (2) Swine. Kidney (target tissue): 1 ppm. (c) Related conditions of use. See § 522.1860 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.